Osteoclast-like cell formation by circulating myeloma B lymphocytes: Role of RANK-L

Leukemia and Lymphoma

Volumn 45, Issue 2, 2004, Pages 377-380

  Calvani, Nicola ^a   Silvertris, Franco ^a   Cafforio, Paola ^a   Dammacco, Franco ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

B lymphocytes; Multiple myeloma; Osteoclast; RANK L; TRAP

Indexed keywords

CD19 ANTIGEN; COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL TRANSFORMATION; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROENVIRONMENT; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL;

AGED; ANTIGENS, CD19; B-LYMPHOCYTES; BONE RESORPTION; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL DIVISION; CELLS, CULTURED; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM CIRCULATING CELLS; OSTEOCLASTS; PHENOTYPE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0842279715     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001595696     Document Type: Article

References (21)

1. Callander, N.S. and Roodman, G.D. (2001) "Myeloma bone disease", Seminars in Hematology, 38(3), 276-285.
2. Szczepek, A.J., Seeberger, K., Wizniak, J., Mant, M.J., Belch, A.R., et al. (1998) "A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase- polymerase chain reaction", Blood, 92(8), 2844-2855.
3. Manabe, N., Kawaguchi, H., Chikuda, H., Miyaura, C., Inada, M., Nagai, R., et al. (2001) "Connection between B lymphocyte and osteoclast differentiation pathways", Journal of Immunology, 167(5), 2625-2631.
4. Durie, B.G. and Salmon, S.E. (1977) Multiple myeloma, macroglobulinemia and monoclonal gammopathies. In Recent Advances in Haematology, edited by A.V. Hollbrand, M.C. Brain and J. Hirsh. Pp. 243-261. New York, NY. Churchill Livingstone.
5. Durie, B.G. and Salmon, S.E. (1975) "A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival", Cancer, 36(3), 842-854.
6. Bull, H., Murray, P.G., Thomas, D., Fraser, A.M. and Nelson, P.N. (2002) "Acid phosphatases", Molecular Pathology, 55(2), 65-72.
7. Higuchi, Y., Ito, M., Tajima, M., Higuchi, S., Miyamoto, N., Nishio, M., et al. (1999) "Gene expression during osteoclast-like cell formation induced by antifusion regulatory protein-1/CD98/4F2 monoclonal antibodies (MAbs): c-src is selectively induced by anti-FRP-1 MAb", Bone, 25(1), 17-24.
8. Walsh, C.A., Beresford, J.N., Birch, M.A., Boothroyd, B. and Gallagher, J.A. (1991) "Application of reflected light microscopy to identify and quantitate resorption by isolated osteoclasts", Journal of Bone and Mineral Research, 6(7), 661-671.
9. James, I.E., Dodds, R.A., Lee-Rykaczewski, E., Eichman, C.F., Connor, J.R., Hart, T.K., et al. (1996) "Purification and characterization of fully functional human osteoclast precursors", Journal of Bone and Mineral Research, 11(11), 1608-1618.
10. Gregoretti, M.G., Bergui, L., Aragno, M., Cremona, O., Marchisio, P.C. and Caligaris-Cappio, F. (1995) "Osteoclast precursors circulate in the peripheral blood of patients with aggressive multiple myeloma", Leukemia, 9(8), 1392-1397.
11. Szczepek, A.J., Bergsagel, P.L., Axelsson, L., Brown, C.B., Belch, A.R. and Pilarski, L.M. (1997) "CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements", Blood, 89(5), 1824-1833.
12. Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., et al. (1999) "OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis", Nature, 397(6717), 315-323.
13. Yoshida, H., Hayashi, S., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T. and Shultz, L.D. (1990) "The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene", Nature, 345(6274), 442-444.
14. Lagasse, E. and Weissman, I.L. (1997) "Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice", Cell, 89(7), 1021-1031.
15. Kastrinakis, N.G., Gorgoulis, V.G., Foukas, P.G., Dimopoulos, M.A. and Kittas, C. (2000) "Molecular aspects of multiple myeloma", Annals of Oncology, 11(10), 1217-1228.
16. Roux, S., Meignin, V., Quillard, J., Meduri, G., Guiochon-Mantel, A., Fermand, J.P., et al. (2002) "RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma", British Journal of Haematology, 117(1), 86-92.
17. Hofbauer, L.C., Neubauer, A. and Heufelder, A.E. (2001) "Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases", Cancer, 92(3), 460-470.
18. Shalhoub, V., Elliott, G., Chiu, L., Manoukian, R., Kelley, M., Hawkins, N., et al. (2000) "Characterization of osteoclast precursors in human blood", British Journal of Haematology, 111(2), 501-512.
19. Croucher, P.I., Shipman, C.M., Lippitt, J., Perry, M., Asosingh, K., Hijzen, A., et al. (2001) "Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma", Blood, 98(13), 3534-3540.
20. Pilarski, L.M., Hipperson, G., Seeberger, K., Pruski, E., Coupland, R.W. and Belch, A.R. (2000) "Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice", Blood, 95(3), 1056-1065.
21. Reiman, T., Seeberger, K., Taylor, B.J., Szczepek, A.J., Hanson, J., Mart, M.J., et al. (2001) "Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone", Blood, 98(9),